We analyzed TNFRSF11B expression in the liver of patients with NASH to investigate the role of OPG and found that the TNFRSF11B mRNA level was reduced in patients with NASH (Fig. 1A). Here, TNFRSF11B is linked to metabolic dysfunction-associated steatohepatitis.